Collagen-Biostimulating Volume · PDLLA + HA

JUVELOOK Volume Treatment in Seoul

JUVELOOK Volume (sold internationally as LENISNA) is a PDLLA + HA collagen-biostimulating injectable for facial volume loss — cheeks, mid-face, and nasolabial folds. It carries roughly 4× the PDLLA dose of base JUVELOOK for deeper volumization, pairing same-day HA support with gradual collagen build over months. It is MFDS-approved in Korea and CE-marked, but NOT FDA-approved. A dermatologist consultation confirms suitability, and individual results vary.

피부과 전문의

Board-Certified

AAD 국제 펠로우

IFAAD

FDA 인증 장비

해당 시술

MFDS 등록

보건복지부

윤상열 원장 감수

피부과 전문의 · 대표원장 · AAD 회원

개요

JUVELOOK Volume in Seoul — PDLLA + HA collagen-biostimulating injectable for cheek hollowing, mid-face volume loss, and nasolabial folds. MFDS-approved, not FDA-approved.

이런 고민에

Cheek hollowing and mid-face volume loss
Nasolabial folds and soft facial contour
Tired, flat, or aged appearance from deflation
Patients preferring gradual, natural volume over immediate filler

권장 대상

Patients with mild-to-moderate facial volume loss wanting a natural, gradual change
Those preferring collagen-biostimulating volume over immediate HA filler
Patients ready for a 2-3 session course at about 1-month intervals
Patients wanting honest regulatory disclosure (MFDS / CE, not FDA)

소요 시간: 20-40 min
권장 횟수: 2-3 at about 1-month intervals
다운타임: Minor (resolves in a few days)
최적 결과: 3-6 months (collagen remodeling)

결과 경과

Same day
Mild swelling, redness, tenderness, or small injection marks. Early volume/hydration effect is not the final result.
Days 1-7
Swelling or bruising gradually improves; the area may feel slightly firm or uneven temporarily.
Weeks 4-8
Collagen stimulation becomes more noticeable — subtle firmness, texture, and soft volume support.
Months 3-6
Gradual collagen change becomes more visible; facial volume and elasticity look more naturally improved.
Months 12-24
Maintenance timing varies; a follow-up session may be considered per skin condition and goals.

사용 장비

JUVELOOK Volume PDLLA + HA collagen biostimulator

JUVELOOK Volume (VAIM PDLLA + HA, intl. LENISNA)

VAIM Co., Ltd. (Korea)MFDS-approved (Korea), CE-marked (EU). NOT FDA-approved.

핵심 사양

Active: PDLLA microspheres + HA carrier (about 4× PDLLA dose of base JUVELOOK)
Mechanism: HA same-day support + PDLLA collagen build over months
Placement: deep dermis or subcutaneous, per treatment area
Course: 2-3 sessions at about 1-month intervals
: Cannula for periorbital and other high-risk zones
: Restoration effect typically observed from around 6 weeks

시술 진행

01
Dermatologist evaluates facial structure, skin quality, volume loss, and goals — confirming suitability or a better route
02
Areas are mapped around facial balance (cheeks, mid-face, nasolabial folds), not simply adding volume
03
After cleansing, JUVELOOK Volume is injected in the deep dermis or subcutaneous layer per area
04
Session takes about 20-40 minutes; guidance on swelling and follow-up timing is provided
05
A 2-3 session course at about 1-month intervals is typical, adjusted to response

“주사제와 에너지 장비는 반드시 의사가 직접 시행하며, 간호사나 테크니션에게 위임하지 않습니다. 본원은 피부과 전문의가 진료를 이끕니다.”
— 윤상열 원장 · 진료원장 · 피부과 전문의 · AAD International Fellow

사후 관리

First 24 hours
Avoid touching, pressing, or rubbing the area. Skip heavy exercise, alcohol, sauna, hot baths, and strong heat. Mild swelling or tenderness may occur.
Days 1-3
Bruising or swelling may become more noticeable before improving. Gentle skincare and sunscreen. Contact the clinic for severe pain or unusual discoloration.
Week 1
Most temporary injection-related reactions improve within several days. Do not massage the area unless your dermatologist instructs it.
Long-term
Maintain sunscreen and a gentle routine. Collagen results are gradual — assess over time. Follow-up sessions may be recommended per your plan.

자주 묻는 질문

Is JUVELOOK Volume the same as a filler, or FDA-approved?

It differs from a traditional HA filler. While HA fillers mainly create immediate volume by filling space, JUVELOOK Volume combines HA with PDLLA to support gradual collagen stimulation, so the final result develops more slowly and naturally. Regulatory status: it is MFDS-approved in Korea and CE-marked, but NOT FDA-approved as an injectable in the US.

How is JUVELOOK Volume different from base JUVELOOK?

Same active ingredients (PDLLA + HA), different formulation. Base JUVELOOK uses smaller particles for superficial-to-mid-dermal skin boosting (texture, fine lines). JUVELOOK Volume — sold internationally as LENISNA — has roughly 4× higher PDLLA dose and a thicker HA carrier for deep-dermal or subcutaneous volumization of the mid-face, cheeks, and folds.

When will I see results, and how many sessions are needed?

Some early change may show soon from the HA component, but collagen-related improvement develops gradually — often noticeable around 4-8 weeks, with more visible change around 3-6 months. Many patients are advised 2-3 sessions at about 1-month intervals; the ideal number depends on volume loss, treatment area, and goals, set after consultation.

What are the most serious risks?

Rare but serious: vascular occlusion (including visual complications) from inadvertent intravascular injection, particularly in glabellar, periorbital, and forehead zones. The Asia-Pacific PDLLA-HA vascular-safety consensus guides safe technique — cannula for high-risk zones, hyaluronidase emergency kit, and anatomy-based depth control. Common transient risks include swelling, bruising, and mild redness; rare late-onset nodules have been documented and are manageable.

주의 · 금기

다음 해당 시 상담 때 알려주세요. 치료가 금지되거나 계획이 조정됩니다.

시술 전 상담에서 금기 사항을 자세히 안내드립니다.

방문 참고

Mild swelling or bruising usually resolves within a few days; bruising can take longer in some patients
Full course is about 2-3 sessions at 1-month intervals — short-trip patients complete one session and continue later
Avoid heat and exercise 24-48h; collagen-driven change develops over 3-6 months after departure

참고 문헌

본 페이지에 기재된 의학적 정보는 아래 1차 자료를 근거로 작성되었습니다. 각 주장(기기 사양·시술 효과·안전성 등)은 해당 문헌을 참조합니다.3 refs

[1]Hybrid PDLLA-HA for Tear Trough Rejuvenation. Aesthetic Plast Surg (Young & Lau) — prospective PDLLA-HA study N=15 (2026).
[2]Safe Injection Technique for PDLLA-HA200 (Visual Impairment Consensus). J Craniofac Surg (Lau et al.) — authoritative PDLLA-HA vascular-safety consensus (2025).
[3]PLLA vs PDLLA Fillers: Comparative Mouse Study. In Vivo (Jang et al.) — independent SNU/Sookmyung PLLA vs PDLLA comparator (2026).